Edition:
United States

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

190.17USD
17 Nov 2017
Change (% chg)

-- (--)
Prev Close
$190.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
395,322
52-wk High
$201.20
52-wk Low
$139.07

Select another date:

Thu, Nov 9 2017

BRIEF-Evoke Pharma signs commercial agreement with Thermo Fisher Scientific

* Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​

BRIEF-Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes

* Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes

BRIEF-Thermo Fisher enters agreement with Blueprint Medicines​

* Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​

Thermo Fisher tops profit estimates; raises full-year forecast

Thermo Fisher Scientific Inc , the world's largest maker of scientific instruments, on Wednesday reported a higher-than-expected quarterly profit, fueled by sales growth in all of its units and contributions from recent acquisitions.

Thermo Fisher tops profit estimates; raises full-year forecast

Oct 25 Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, on Wednesday reported a higher-than-expected quarterly profit, fueled by sales growth in all of its units and contributions from recent acquisitions.

BRIEF-Thermo Fisher Scientific reports Q3 Adj EPS of $2.31

* Q3 GAAP earnings per share $1.34; Q3 adjusted earnings per share $2.31

BRIEF-TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CFO

* TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER

EU mergers and takeovers (Aug 25)

BRUSSELS, Aug 25 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

EU mergers and takeovers (Aug 24)

BRUSSELS, Aug 23 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

BRIEF-Thermo Fisher Scientific announces receipt of all required regulatory approvals for proposed acquisition of Patheon

* Thermo Fisher Scientific announces receipt of all required regulatory approvals for proposed acquisition of patheon

Select another date: